medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2020, Number 02

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (02)

Mixed ovarian germ cell tumor, an unusual combination

Polanco-Sosa AL, Peña-Montemayor AK, Mireles-García AM

Language: Spanish
References: 10
Page: 123-126
PDF size: 189.26 Kb.


ABSTRACT

Background: Ovarian germ cell tumors are rare, clinically and biologically heterogeneous tumors, formed by several types of histopathologically different tumors that derive from primitive cells and that are nested ectopically, proliferate and undergo malignant transformation.
Clinical case: A 10-year-old patient who came to consult for weight loss and abdominal pain as well as an increase in abdominal perimeter of rapid growth. A fixed abdominal tumor of 20 x 20 cm is scanned and found, as well as palpable left cervical lymph node. Tumor markers showing alphafetoprotein were taken. 1104 ng/ mL, B-HCG 865.6 mUi/mL. The CT scan showed a lesion that occupies abdomen and pelvis with a heterogeneous density of 14 x 12 x 10 cm. It was decided to intervene surgically and complement with chemotherapy; The pathology report reported being a mixed germ tumor with 5 very aggressive histological types that ended with the patient's life 9 months later.
Conclusion: Malignant germ cell tumors are extremely malignant and rapidly growing, with a peak incidence in girls, adolescents and young women. Symptoms are related to rapid growth characterized by pelvic-abdominal pain related to capsular distention, hemorrhage or necrosis. Surgical staging is the first step in the treatment of ovarian germ cell cancer. The survival rate is greater than 95% in early stage (l-ll), 80% in stage lll and 60% in stage lV, so the diagnosis and timely treatment is the most important.


REFERENCES

  1. Pardo-García N, et al. Tumores de células germinales. Clin Transl Oncol. 2005; 7 (8): 361-9.

  2. Goyal LD, et al. Malignant mixed germ cell tumour of ovary- an unusual combination and review of literature. J Ovarian Res. 2014; 7: 91. ttps://doi.org/10.1186/s13048-014-0091-5

  3. Park JY, et al. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors. Gynecol Oncol. 2015; 137 (3): 418-22. ttps://doi.org/10.1016/j. ygyno.2015.03.054

  4. Pectasides D, et al. Germ cell tumors of the ovary. Cancer Treat Rev. 2008; 34 (5): 427-41. https://doi.org/10.1016/j. ctrv.2008.02.002

  5. Vargas-Hernández VM, et al. Tumor de células germinales de ovario. Presentación clínica y su tratamiento en 15 casos. Rev Hosp Jua Mex 2014; 81(4): 214-19.

  6. Torres-Lobatón A. Tumores de células germinales ováricas malignas. Estado actual del diagnóstico y tratamiento, Ginecol Obstet Mex. 2014; 82 (3): 177-87.

  7. Renaud EJ, et al. Ovarian masses in the child and adolescent: An American Pediatric Surgical Association Outcomes and Evidence-Based Practice Committee systematic review, J Pediatr Surg. 2019; 54 (3): 369-77.. https://doi. org/10.1016/j.jpedsurg.2018.08.058

  8. Shah R, et al. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults. Gynecol Oncol. 2018 Aug;150(2):253-260. https://doi.org/10.1016/j.ygyno.2018.05.025

  9. Linasmita V, et al. Recent Management of malignant ovarian germ cell tumors: A study of 34 cases. J. Obstet. Gynaecol. Res. 2010; 25 (5). https://doi. org/10.1111/j.1447-0756.1999.tb01169.x

  10. Liang P, et al. Treatment approach and prognosis of pediatric and adolescent nonepithelial malignant ovariantumors: A retrospective prognosis analysis, J Pediatr Adolesc Gynecol. 2018; 31 (3): 304-10. https://doi.org/10.1016/j. jpag.2017.09.011




2020     |     www.medigraphic.com